Personnel Information

写真a

YUASA Mari


Job title

Assistant Professor

Mail Address

The inquiry by e-mail is 《here

Degree 【 display / non-display

  • Doctor of Biomedical engineering

Campus Career 【 display / non-display

  • 2008.12
    -
    Now
    Tokyo Medical and Dental University, Institute of Biomaterials and Bioengineering, Biomolecular Chemistry, Organic and Medicinal Chemistry, Project Assistant Professor
  • 2013.07
    -
    2017.03
    Tokyo Medical and Dental University, Institute of Biomaterials and Bioengineering, Biofunctional Restoration, Biodesign, Assistant Professor
  • 2014.10
    -
    2016.02
    Tokyo Medical and Dental University, Institute of Biomaterials and Bioengineering, Medical and Dental Device Technology Incubation Center, Assistant Professor
  • 2017.04
    -
    Now
    Tokyo Medical and Dental University, Institute of Biomaterials and Bioengineering, Biomolecular Chemistry, Organic and Medicinal Chemistry, Assistant Professor
 

Published Papers & Misc 【 display / non-display

  • Shinya Fujii, Eriko Kikuchi, Honoka Suzuyama, Yuko Watanabe, Mari Ishigami-Yuasa, Hiroyuki Masuno, Takayasu Mori, Kiyoshi Isobe, Shinichi Uchida, Hiroyuki Kagechika. Structural Development of Salicylanilide-Based SPAK Inhibitors as Candidate Antihypertensive Agents. ChemMedChem. 2021.06; ( PubMed, DOI )

  • Shunta Nagashima, Junichi Maruyama, Kaori Honda, Yasumitsu Kondoh, Hiroyuki Osada, Makiko Nawa, Ken-Ichi Nakahama, Mari Ishigami-Yuasa, Hiroyuki Kagechika, Haruhiko Sugimura, Hiroaki Iwasa, Kyoko Arimoto-Matsuzaki, Hiroshi Nishina, Yutaka Hata. CSE1L promotes nuclear accumulation of transcriptional coactivator TAZ and enhances invasiveness of human cancer cells. J Biol Chem. 2021.03; 297 (1): 100803. ( PubMed, DOI )

  • Shintaro Sakakitani, Katarzyna A Podyma-Inoue, Rina Takayama, Kazuki Takahashi, Mari Ishigami-Yuasa, Hiroyuki Kagechika, Hiroyuki Harada, Tetsuro Watabe. Activation of β2-adrenergic receptor signals suppresses mesenchymal phenotypes of oral squamous cell carcinoma cells. Cancer Sci. 2021.01; 112 (1): 155-167. ( PubMed, DOI )

  • Shinya Fujii, Eriko Kikuchi, Yuko Watanabe, Honoka Suzuyama, Mari Ishigami-Yuasa, Takayasu Mori, Kiyoshi Isobe, Shinichi Uchida, Hiroyuki Kagechika. Structural development of N-(4-phenoxyphenyl)benzamide derivatives as novel SPAK inhibitors blocking WNK kinase signaling. Bioorg. Med. Chem. Lett.. 2020.09; 30 (17): 127408. ( PubMed, DOI )

  • Hitomi Koga, Mai Negishi, Marie Kinoshita, Shinya Fujii, Shuichi Mori, Mari Ishigami-Yuasa, Emiko Kawachi, Hiroyuki Kagechika, Aya Tanatani. Development of Androgen-Antagonistic Coumarinamides with a Unique Aromatic Folded Pharmacophore. Int J Mol Sci. 2020.08; 21 (15): ( PubMed, DOI )

display all >>

Conference Activities & Talks 【 display / non-display

  • 湯浅 磨里、影近 弘之. ヒト前立腺がん細胞におけるタミバロテンとヒストン脱アセチル化 酵素阻害薬の併用効果の検討および作用機序の解明. 第79回日本癌学会学術集会 2020.10.01

  • 飯沼 大翔,柴 喜坤,森 修一,湯浅 磨里,呉林 なごみ,村山 尚,影近 弘之. 小胞体Ca2+評価系に基づいた選択的2型リアノジン受容体抑制剤の創製 . 日本薬学会第140年会 2020.03.25 京都

  • Nagomi Kurebayashi, Takashi Murayama,Masato Konishi, Shuichi Mori, Mari Ishigami-Yuasa, Hiroyuki Kagechika,Haruo Ogawa, Sachio Morimoto, Takashi Sakurai. EFFECTS OF RYR2 INHIBITORS ON CA2+ SIGNALS IN HEALTHY AND DISEASED CARDIAC CELLS.. Biophysical Society 2020 2020.02.15 San Diego

  • Hiroyuki Matsukawa, Takashi Murayama, Takuya Kobayashi, Nagomi Kurebayashi,Toshiko Yamazawa, Mari Ishigami-Yuasa, Shuichi Mori, Hiroyuki Kagechika, Takashi Sakurai. CHARACTERIZATION OF NOVEL RYR1-SELECTIVE INHIBITORS IDENTIFIED BY HIGHTHROUGHPUT SCREENING USING ER CA2+ MEASUREMENT. Biophysical Society 2020 2020.02.15 San Diego

  • Mari Yuasa, Hisao Ekimoto, Hiyroyuki Kagechika. HDAC inhibition enhances the inhibitory effect of Am80, a synthetic retinoid, in prostate cancer . 2019.10.20

display all >>

Awards & Honors 【 display / non-display

  • Shiseido Female Researcher Science Grant,Shiseido,2020.06